Gulnara Ispossunova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gulnara Ispossunova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aiym Amangeldi
School of General Medicine-2 Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan
1 shared publication - Akmaral Aitmanbetova
Department of Public Health, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan
1 shared publication - Anel Ispossunova
Medical Center “DNA”, Kostanay 110000, Kazakhstan
1 shared publication - Ardak Nurbakyt
Department of Public Health, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan
1 shared publication - Dejan Nikolic
Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Filip Milanovic
Department of Pediatric Surgery, University Children’s Hospital, 11000 Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
Preventive Strategies and Biomarkers in Male Reproductive Health from Multidisciplinary Perspective: Narrative Review
The objective of this review is to synthesize current knowledge and evidence on male reproductive health by addressing preventive medicine strategies and biomarkers, as well as to provide clinicians, researchers, and policy makers with a coherent framework for prevention of male reproductive health. In this review male (in)fertility and determinants of male reproductive health as well as preventive strategies with special attention to primary, secondary and tertiary prevention in male reproductive health will be analyzed. From primary preventive measures: education, weight management, physical activity, sleep, healthy diet, alcohol and smoking consumption will be assessed, while from secondary preventive measures: sexually transmitted infection (STI) from the point of transmission prevention, testicular self-examination, hormonal testing and management, chronic diseases and semen analysis will be discussed; and from tertiary preventive measures: treatment of STI, treatment of congenital abnormalities, infertility treatment and urogenital cancer treatment will be elaborated. Additionally, biomarkers in male reproductive health will be synthesized and discussed. Bridging the gap between evidence and practice will ultimately lead to better understanding of the complex state of male reproductive health, thus minimizing the potential missed windows of opportunities in timely adequate preventive interventions implementations, as well as on time diagnostic and optimal treatment options.
Open AccessPreventive Strategies and Biomarkers in Male Reproductive Health from Multidisciplinary Perspective: Narrative Review
The objective of this review is to synthesize current knowledge and evidence on male reproductive health by addressing preventive medicine strategies and biomarkers, as well as to provide clinicians, researchers, and policy makers with a coherent framework for prevention of male reproductive health. In this review male (in)fertility and determinants of male reproductive health as well as preventive strategies with special attention to primary, secondary and tertiary prevention in male reproductive health will be analyzed. From primary preventive measures: education, weight management, physical activity, sleep, healthy diet, alcohol and smoking consumption will be assessed, while from secondary preventive measures: sexually transmitted infection (STI) from the point of transmission prevention, testicular self-examination, hormonal testing and management, chronic diseases and semen analysis will be discussed; and from tertiary preventive measures: treatment of STI, treatment of congenital abnormalities, infertility treatment and urogenital cancer treatment will be elaborated. Additionally, biomarkers in male reproductive health will be synthesized and discussed. Bridging the gap between evidence and practice will ultimately lead to better understanding of the complex state of male reproductive health, thus minimizing the potential missed windows of opportunities in timely adequate preventive interventions implementations, as well as on time diagnostic and optimal treatment options.